What is the purpose of this trial?
The purpose of this study is to determine the safety and tolerability of entinostat used in combination with pembrolizumab in patients with Non-small Cell Lung Cancer. Additionally the purpose of the study is to assess how effective entinostat and pembrolizumab are in combination in patients with Non-small Cell Lung Cancer and Melanoma.
Start Date: 02/15/2017
End Date: 10/31/2017
Last Updated: 02/22/2018
Study HIC#: 1509016482